We also added MSS CRC CM to CD8+ T cell culture and observed no effect on cell activation and effector function, indicated by the CD44 surface level and cytokine productions, respectively (Figs. 1D–F and EV1D–F). The gene discussed is CD44; the disease is colorectal carcinoma.